Meet the CARDI Fellows: Charlotte Neville
- Northern Ireland
- Republic of Ireland
The CARDI Leadership Programme into Ageing Research funds and supports a new generation of leaders in ageing research in Ireland, North and South.
The programme is funded by the Health and Social Care Research and Development Division Northern Ireland and The Atlantic Philanthropies.
The new CARDI Fellows were announced at the inaugural meeting of the CARDI Leadership Programme in Ageing Research in Belfast (Monday 15 Sept 2014). In this series of articles CARDI introduces the Fellows:
Dr Charlotte Neville
Dr Charlotte Neville obtained her PhD in nutritional epidemiology in the Centre for Public Health, Queen’s University Belfast in 2010. She also holds a BSc Honours degree in Human Nutrition and a M Phil from the University of Ulster. Her research has centred around the role of diet and lifestyle on health and disease outcomes including obesity, cardiovascular disease, musculoskeletal health and cognitive health, ranging from adolescent populations through to older adults. In recent years, Dr Neville’s research has expanded into lifestyle and ageing. She was trial manager of the Ageing and Dietary Intervention Trial (ADIT) examining the effect of increased fruit and vegetable consumption on measures of immune function and musculoskeletal health in older adults.
In her research, as a CARDI Fellow, Dr Neville will explore the association between fruit and vegetable intake, retinal microvascular health and cognitive decline and dementia risk. Accurate assessment of dietary intake in older populations is vital to unravel the potential role of diet in healthy ageing. The research will examine the efficacy of assessment methods currently used in NICOLA and test other potential dietary assessment methods that may be particularly suited to older people. Her research will also draw on TILDA to examine the topic of dietary intake and its link to dementia in older people.
In 2012 it was estimated that there were 35.6 million people worldwide with dementia and that the number will approximately double every 20 years because of growing life expectancy. The ability to identify those at high risk of dementia at an early stage and set in place strategies to reduce age-related morbidity and chronic disease prevalence can help encourage healthy ageing, and have financial and societal benefits.